Results 51 to 60 of about 4,711,883 (288)

How structural disorder and polyelectrolyte properties of prothymosin α enable its large interactome

open access: yesFEBS Letters, EarlyView.
In this review, complexes of the fully disordered and highly negatively charged prothymosin α are collected, described, and discussed. Linked to its poly‐electrostatic character, prothymosin α engages a large interactome through multiple different binding modes ranging from fully disordered complexes to short linear motif (SLiM)‐driven interactions ...
Ketty C. Tamburrini   +3 more
wiley   +1 more source

Genomic and transcriptomic analyses identify distinctive features of triple-negative inflammatory breast cancer

open access: yesnpj Precision Oncology
Triple-negative inflammatory breast cancer (TN-IBC) is the most aggressive type of breast cancer, yet its defining genomic, molecular, and immunological features remain largely unknown.
Xiaoping Wang   +23 more
doaj   +1 more source

Association between local inflammation and breast tissue age-related lobular involution among premenopausal and postmenopausal breast cancer patients. [PDF]

open access: yesPLoS ONE, 2017
Increased levels of pro-inflammatory markers and decreased levels of anti-inflammatory markers in the breast tissue can result in local inflammation. We aimed to investigate whether local inflammation in the breast tissue is associated with age-related ...
Mirette Hanna   +8 more
doaj   +1 more source

A New N-staging System for Predicting Postoperative Survival of M0 Stage Inflammatory Breast Cancer

open access: yesZhongliu Fangzhi Yanjiu, 2022
Objective To establish a new N-stage system combining the number of metastatic lymph nodes and the ratio of metastatic lymph nodes for postoperative M0 stage inflammatory breast cancer patients.
SUI Daxing, WANG Xueying, ZHANG Jiaxin
doaj   +1 more source

Inflammatory breast cancer-importance of breast imaging

open access: yesEuropean Journal of Surgical Oncology, 2018
Inflammatory breast cancer (IBC) is a rare form of primary cancer and accounts for only 1-5 % of all breast cancer types.[1–3] It is classified as T4d stage by TNM classification,[4] the most aggressive form of breast cancer with a 20%–30% incidence of distant metastasis at the time of diagnosis[5] and poorer prognosis than the non-IBC locally advanced
Papalouka, Vasiliki, Gilbert, Fiona J
openaire   +3 more sources

Hijacking emergency granulopoiesis: Neutrophil ontogeny and reprogramming in cancer

open access: yesMolecular Oncology, EarlyView.
Neutrophils are highly plastic innate immune cells; their functions in cancer extend beyond the tumour microenvironment. This Review summarises current understanding of neutrophil maturation and heterogeneity and highlights tumour‐induced granulopoiesis as a systemic programme that expands immature, immunosuppressive neutrophils via tumour‐derived ...
Gabriela Marinescu, Yi Feng
wiley   +1 more source

Blockade of store-operated calcium entry sensitizes breast cancer cells to cisplatin therapy via modulating inflammatory response

open access: yesSaudi Pharmaceutical Journal, 2023
Store-operated calcium entry (SOCE) is an important pathway for calcium signaling that regulates calcium influx across the plasma membrane upon the depletion of calcium stores in the endoplasmic reticulum.
Abdullah S. Alhamed   +11 more
doaj   +1 more source

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

Challenging a Misnomer? The Role of Inflammatory Pathways in Inflammatory Breast Cancer

open access: yesMediators of Inflammation, 2017
Inflammatory breast cancer is a rare, yet highly aggressive form of breast cancer, which accounts for less than 5% of all locally advanced presentations.
Riley J. Morrow   +3 more
doaj   +1 more source

An update on inflammatory breast cancer

open access: yesOncology Reviews, 2011
Inflammatory breast cancer is one of the most aggressive forms of breast cancer. Once considered to be a uniformly fatal disease, treatment of this entity has evolved significantly over the last two decades.
P. Thapaliya, N. J. Karlin
doaj   +1 more source

Home - About - Disclaimer - Privacy